pomalidomide has been researched along with indirubin in 1 studies
| Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (indirubin) | Trials (indirubin) | Recent Studies (post-2010) (indirubin) |
|---|---|---|---|---|---|
| 623 | 121 | 552 | 347 | 3 | 184 |
| Protein | Taxonomy | pomalidomide (IC50) | indirubin (IC50) |
|---|---|---|---|
| Glycogen synthase kinase-3 beta | Sus scrofa (pig) | 1 | |
| [Tau protein] kinase | Sus scrofa (pig) | 1 | |
| Cyclin-dependent kinase 14 | Homo sapiens (human) | 2.2 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 8.25 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2 | |
| Insulin receptor | Homo sapiens (human) | 2 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 7.74 | |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | 2.2 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 8.8333 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 1 | |
| Cyclin-A2 | Homo sapiens (human) | 3.525 | |
| Cyclin-dependent kinase 11B | Homo sapiens (human) | 2.2 | |
| Kit ligand | Homo sapiens (human) | 2 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 4.85 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 3.24 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 2 | |
| Cyclin-dependent kinase 8 | Homo sapiens (human) | 2.2 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 1.5 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.8515 | |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 3 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 6.15 | |
| Cyclin-dependent kinase 16 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 17 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 18 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 6.7143 | |
| Cyclin-dependent kinase 10 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 20 | Homo sapiens (human) | 2.2 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 8.25 | |
| Cyclin-dependent kinase 15 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 19 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 1 | |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | 2.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Chen, D; Gu, Z; He, B; Li, Y; Lin, H; Lin, S; Liu, T; Wang, J; Wang, Y; Zhao, Y | 1 |
1 other study(ies) available for pomalidomide and indirubin
| Article | Year |
|---|---|
Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6.
Topics: Animals; Drug Development; HeLa Cells; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Indoles; Inflammasomes; K562 Cells; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Proteolysis; Structure-Activity Relationship; Thalidomide | 2021 |